Published in Am J Physiol on September 01, 1969
Autonomic disturbance at onset of acute myocardial infarction. Br Med J (1972) 2.50
Structural neuroplasticity following T5 spinal cord transection: increased cardiac sympathetic innervation density and SPN arborization. Am J Physiol Regul Integr Comp Physiol (2010) 1.47
Role of protons in activation of cardiac sympathetic C-fibre afferents during ischaemia in cats. J Physiol (1999) 1.44
Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings. J Physiol (1973) 1.35
Spinal sympathetic reflexes initiated by coronary receptors. J Physiol (1971) 1.25
Left and right heart haemodynamics during spontaneous angina pectoris. Comparison between angina with ST segment depression and angina with ST segment elevation. Br Heart J (1975) 1.17
Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev (2011) 1.17
Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. J Clin Invest (1980) 1.11
Left ventricular performance and related haemodynamic changes in Prinzmetal's variant angina pectoris. Br Heart J (1971) 1.01
Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J Physiol (2005) 0.96
Afferent sympathetic unmyelinated fibres with left ventricular endings in cats. J Physiol (1979) 0.87
Myocardial ischemia-mediated excitatory reflexes: a new function for thromboxane A2? Am J Physiol Heart Circ Physiol (2008) 0.87
Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides. Am J Physiol Regul Integr Comp Physiol (2013) 0.85
Prognostic value of heart rate variability after acute myocardial infarction in the era of immediate reperfusion. Herzschrittmacherther Elektrophysiol (2009) 0.84
Vagal stimulation for heart diseases: from animals to men. An example of translational cardiology. Neth Heart J (2013) 0.83
A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers. J Transl Med (2014) 0.82
Vagal and sympathetic reflexes of left ventricular origin on the efferent activity of cardiac and renal nerves on anaesthetized cats. Basic Res Cardiol (1981) 0.82
Metabolic requirements for release of endogenous noradrenaline during myocardial ischaemia and anoxia. Br J Pharmacol (1987) 0.82
Targeted ablation of cardiac sympathetic neurons reduces resting, reflex and exercise-induced sympathetic activation in conscious rats. Am J Physiol Heart Circ Physiol (2009) 0.82
Cardiac and whole body [3H]noradrenaline kinetics in ischaemic heart disease: contrast between unstable anginal syndromes and pacing induced ischaemia. Br Heart J (1989) 0.81
Targeted ablation of cardiac sympathetic neurons reduces the susceptibility to ischemia-induced sustained ventricular tachycardia in conscious rats. Am J Physiol Heart Circ Physiol (2010) 0.80
Clinical and haemodynamic correlates of heart rate turbulence as a non-invasive index of baroreflex sensitivity in chronic heart failure. Clin Sci (Lond) (2011) 0.80
Plasma levels of copeptin in patients with coronary heart disease. Heart Vessels (2009) 0.79
Intracellular recordings from the stellate ganglion of the cat. J Physiol (1982) 0.79
Management of pain with regional analgesia. Postgrad Med J (1984) 0.79
Inhibition of cardiac sympathetic nerve activity during intravenous administration of lidocaine. J Clin Invest (1983) 0.79
Cardiac spinal deafferentation reduces the susceptibility to sustained ventricular tachycardia in conscious rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.78
Differences in autonomic nerve function in patients with silent and symptomatic myocardial ischaemia. Br Heart J (1994) 0.78
Temporal profile and mechanisms of the prompt sympathoexcitation following coronary ligation in Wistar rats. PLoS One (2014) 0.77
Changes in ventricular fibrillation threshold during repeated short-term coronary occlusion and release. Basic Res Cardiol (1978) 0.77
ASICs and cardiovascular homeostasis. Neuropharmacology (2015) 0.76
B-endorphin release in patients after spontaneous and provoked acute myocardial ischemia. Br Heart J (1993) 0.75
Chemoreceptors of the heart. Trans Am Clin Climatol Assoc (1977) 0.75
Differing autonomic responses to dobutamine stress in the presence and absence of myocardial ischaemia. J Physiol (2015) 0.75
The Effect of Slow Coronary Artery Flow on Microvolt T-Wave Alternans. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
Cardiac autonomic innervation. J Nucl Cardiol (2016) 0.75
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
The long QT syndrome. Prospective longitudinal study of 328 families. Circulation (1991) 3.99
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79
The long Q-T syndrome. Am Heart J (1975) 3.75
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation (1994) 3.64
Early and late effects of exercise and athletic training on neural mechanisms controlling heart rate. Cardiovasc Res (1993) 3.61
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Low penetrance in the long-QT syndrome: clinical impact. Circulation (1999) 3.14
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation (2000) 2.81
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation (1994) 2.79
Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation (1996) 2.70
Idiopathic long QT syndrome: progress and questions. Am Heart J (1985) 2.59
Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens (1995) 2.58
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50
Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation (1997) 2.49
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res (1991) 2.41
A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry (2001) 2.32
Pathophysiology and prevention of atrial fibrillation. Circulation (2001) 2.31
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res (1996) 2.29
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet (1983) 2.18
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation (2001) 2.08
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Blood-pressure control in the hypertensive population. Lancet (1997) 2.05
Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation (1990) 2.03
Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J (1975) 2.03
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens (2007) 2.01
Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J (1994) 1.94
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation (1975) 1.92
Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension (1988) 1.90
Entropy, entropy rate, and pattern classification as tools to typify complexity in short heart period variability series. IEEE Trans Biomed Eng (2001) 1.81
Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension (1987) 1.80
White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? J Hypertens (1996) 1.79
The long QT syndrome: a prospective international study. Circulation (1985) 1.77
The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability. Blood Press (1997) 1.76
Compliance to hypertension guidelines in clinical practice: a multicentre pilot study in Italy. J Hum Hypertens (2002) 1.75
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol (2000) 1.74
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res (1983) 1.74
Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens (1998) 1.73
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation (2000) 1.72
Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol (2001) 1.71
Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am J Cardiol (1987) 1.70
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press (1994) 1.70
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension (1988) 1.69
Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation (1988) 1.67
Molecular diagnosis in a child with sudden infant death syndrome. Lancet (2001) 1.66
Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation (1984) 1.63
Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation (1982) 1.61
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J (2000) 1.59
Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet (1994) 1.55
Oscillatory patterns in sympathetic neural discharge and cardiovascular variables during orthostatic stimulus. Circulation (2000) 1.55
Impaired heart rate variability in patients with chronic Chagas' disease. Am Heart J (1991) 1.54
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol (1976) 1.53
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation (1994) 1.51
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. J Hypertens (2000) 1.48
Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation (1995) 1.48
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
The 1996 report of a World Health Organization expert committee on hypertension control. J Hypertens (1996) 1.45
Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst (1988) 1.45
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation (1999) 1.44
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. Hypertension (1990) 1.43
The QT interval throughout the first 6 months of life: a prospective study. Circulation (1982) 1.43
Comparison between invasive and non-invasive measurements of baroreflex sensitivity; implications for studies on risk stratification after a myocardial infarction. Eur Heart J (2000) 1.43
Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum Mol Genet (1999) 1.43
Comparison of low-dose dobutamine ventriculography with low-dose dobutamine echocardiography for predicting regional improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol (2000) 1.42
Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death. Circulation (1994) 1.41
Metabolic syndrome and biventricular hypertrophy in essential hypertension. J Hum Hypertens (2008) 1.39
Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation (1998) 1.39
Cardiac sympathetic innervation and the sudden infant death syndrome. A possible pathogenetic link. Am J Med (1976) 1.38
The phototherapy light visor: more to it than meets the eye. Am J Psychiatry (1995) 1.38
Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens (2001) 1.36
Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens (2001) 1.36
High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens (2001) 1.35
Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings. J Physiol (1973) 1.35
Consideration of the fundamental mechanisms eliciting cardiac pain. Am Heart J (1982) 1.34
The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. Eur Heart J (1985) 1.30
Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation (1980) 1.30
Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference. Groupe Evaluation & Measure of the French Society of Hypertension. J Hypertens (2000) 1.29
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology. Eur Heart J (1999) 1.29
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. J Hypertens Suppl (1984) 1.25